BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 9, 2016
View Archived Issues
Capella BioScience completes series A financing to progress antibody pipeline
Read More
Omeros initiates its phase III program for OMS-721
Read More
Sanofi Pasteur and Merck & Co. announce intent to end joint vaccines operations in Europe
Read More
XBiotech submits MAA for candidate colorectal cancer therapy
Read More
Jiangsu Hengrui Medicine discloses SLC34A2 inhibitors
Read More
Eisai patents FGFR-1 inhibitors
Read More
Teligene presents protein kinase inhibitors
Read More
GeoVax Labs reports findings on simian analogue of GOVX-B11 HIV vaccine
Read More
Stealth BioTherapeutics begins phase II trial of elamipretide in FCED
Read More
RedHill Biopharma reports final phase III results for RHB-105
Read More
Liver injury model reveals role of CD147 in inflammation in liver disease
Read More
Citius Pharmaceuticals signs letter of intent to acquire Leonard Meron Biosciences
Read More
EyeGate acquires Jade Therapeutics
Read More
Study shows p-Tau and Ki-67 as valid biomarkers in skin cancer
Read More
Affymetrix awarded grant to assess value of noninvasive genomic profiling of bladder cancer
Read More
Theranostics Health to join Amarantus Diagnostics and Avant Diagnostics business combination
Read More
HLA allele associated with hidradenitis suppurativa
Read More
Novel tumorigenic driver mutations identified in basal cell carcinoma of the skin
Read More
Helix announces amendments to phase I/II study of L-DOS-47 in Poland
Read More
Bio-Path enters sponsored pancreatic cancer research agreement with MD Anderson
Read More
Ipsen and PeptiMimesis establish research partnership for novel therapeutic peptides in oncology
Read More
Inhibitor of apoptosis protein BIRC3 affects response to glioblastoma therapy
Read More
CFDA approves Roche's CINtec PLUS Cytology test
Read More
